Approval · Notice of Compliance 4859 · 1995

LIN-AMOX: Notice of Compliance 4859

Issued September 15, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 4859
Date: September 15, 1995
Company: Linson Pharma Co.Montreal, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Antibiotic

Products in this notice

Brand	DIN	Status today
LIN-AMOX	02181487	Cancelled Post Market
LIN-AMOX	02181495	Cancelled Post Market
LIN-AMOX	02181509	Cancelled Post Market
LIN-AMOX	02181517	Cancelled Post Market

Medicinal ingredients

AMOXICILLIN TRIHYDRATE 250 MG per CAP
AMOXICILLIN TRIHYDRATE 500 MG per CAP
AMOXICILLIN TRIHYDRATE 125 MG per 5ML
AMOXICILLIN TRIHYDRATE 250 MG per 5ML